Proteomics in prenatal diagnosis

Expert Review of Proteomics

Volumn 6, Issue 2, 2009, Pages 111-113

  Kolialexi, Aggeliki ^a   Tsangaris, George T ^b   Mavrou, Ariadni ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AMNION FLUID ANALYSIS; ANEUPLOIDY; CHROMOSOME ABERRATION; EDITORIAL; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PREGNANCY; PRENATAL DIAGNOSIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; AMNION FLUID; FEMALE; METABOLISM; METHODOLOGY;

AMNIOTIC FLUID; ANEUPLOIDY; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; PROTEOMICS;

EID: 66849132094     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.09.6     Document Type: Editorial

References (18)

1. Pellicer A, Albert C, Mercader A et al. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factor. Fertil. Steril. 71, 482-489 (1999).
2. Wunder DM, Kretschmer R, Bersinger NA. Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles. Hum. Reprod. 20, 1266-1271 (2005).
3. Liberatori S, Bini L, De Felice C et al. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis 18, 2816-2822 (1997).
4. Park SJ, Yoon WG, Song JS et al. Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Proteomics 6, 349-363 (2006).
5. Tsangaris GT, Kolialexi A, Karamessinis PM et al. The normal human amniotic fluid supernatant proteome. In vivo 20, 479-490 (2006).
6. Nagalla SR, Canick JA, Jacob T et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J. Proteome Res. 6, 1245-1257 (2007).
7. Nilsson S, Ramström M, Palmblad M et al. Explorative study of the protein composition of amniotic fluid by liquid chromatography electro-spray ionization Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 3, 884-889 (2004).
8. Michel PE, Crettaz D, Morier P et al. Proteome analysis of human plasma and amniotic fluid by off-gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 27, 1169-1181 (2006)
9. Queloz PA, Crettaz D, Thadikkaran L et al. Proteomic analyses of amniotic fluid: potential applications in health and diseases. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 850, 336-342 (2006).
10. Michaels JE, Dasari S, Pereira L et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J. Prot. Res. 6, 1277-1285 (2007).
11. Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol. Cell. Proteomics 6, 1406-1415 (2007).
12. Tsangaris G, Weitzdörfer R, Pollak D et al. The amniotic fluid cell proteome. Electrophoresis 26, 1168-1173 (2005).
13. Oh JE, Fountoulakis M, Juranville JF et al. Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool? Proteomics 4, 1145-1158 (2004).
14. Wang TH, Chang YL, Peng HH et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat. Diagn. 25, 559-566 (2005).
15. Tsangaris GT, Karamessinis P, Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6, 4410-4419 (2006).
16. Mavrou A, Anagnostopoulos AK, Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses. J. Proteome Res. 7, 1862-1866 (2008).
17. Wang TH, Chao AS, Chen JK et al. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil. Steril. DOI: 10.1016/j.fertnstert. 2008.05.038 (2008) (Epub ahead of print).
18. Kolialexi A, Tsangaris GT, Papantoniou N et al. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat. Diagn. 28, 691-698 (2008).